MP29-17 HYDROGEN SULFIDE TREATMENT MITIGATES DONOR TISSUE NECROSIS DURING PROLONGED COLD STORAGE AND IMPROVES SURVIVAL FOLLOWING ALLOGENEIC RENAL TRANSPLANTATION. | Zendy

AI Assistant Blog Pricing

MP29-17 HYDROGEN SULFIDE TREATMENT MITIGATES DONOR TISSUE NECROSIS DURING PROLONGED COLD STORAGE AND IMPROVES SURVIVAL FOLLOWING ALLOGENEIC RENAL TRANSPLANTATION.

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.